Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

mRNA vaccines expressing homo-prototype/Omicron and hetero-chimeric RBD-dimers against SARS-CoV-2

14 Sept 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunotherapy and Immune Responses
Share to RNA Interference and Gene Delivery
Share to SARS-CoV-2 and COVID-19 Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 36104506
DOI: 10.1038/s41422-022-00720-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

mRNA vaccines expressing homo-prototype/Omicron and hetero-chimeric RBD-dimers against SARS-CoV-2PMID 36104506Read ↗

Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variantSemantic proximity Read ↗

KP.2-based monovalent mRNA vaccines robustly boost antibody responses to SARS-CoV-2Semantic proximity Read ↗

Rapid evaluation of heterologous chimeric RBD-dimer mRNA vaccine for currently-epidemic Omicron sub-variants as booster shot after inactivated vaccineSemantic proximity Read ↗

Messenger RNA vaccines against SARS-CoV-2Semantic proximity Read ↗

mRNA Vaccines: A Prospective Analysis of Long-term, Multi-target, and Autoimmune DisordersSemantic proximity Read ↗

Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2Semantic proximity Read ↗

Circular RNA vaccines against SARS-CoV-2 and emerging variantsSemantic proximity Read ↗

A potential bivalent mRNA vaccine candidate protects against both RSV and SARS-CoV-2 infectionsSemantic proximity Read ↗

mRNA based vaccines provide broad protection against different SARS-CoV-2 variants of concernSemantic proximity Read ↗

Current Developments and Challenges of mRNA VaccinesSemantic proximity Read ↗

Omicron: Call for updated vaccinesSemantic proximity Read ↗

mRNA cancer vaccines: Advances, trends and challengesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.